These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12828576)

  • 1. Clinical implication of plasma natriuretic peptides in children with ventricular septal defect.
    Suda K; Matsumura M; Matsumoto M
    Pediatr Int; 2003 Jun; 45(3):249-54. PubMed ID: 12828576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secretion patterns of brain natriuretic peptide and atrial natriuretic peptide in patients with or without pulmonary hypertension complicating atrial septal defect.
    Nagaya N; Nishikimi T; Uematsu M; Kyotani S; Satoh T; Nakanishi N; Matsuo H; Kangawa K
    Am Heart J; 1998 Aug; 136(2):297-301. PubMed ID: 9704693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between hemodynamics and plasma atrial natriuretic peptide in children with ventricular septal defect or patent ductus arteriosus.
    Dai ZK; Huang TY; Wu JR; Huang MY; Dai ZR
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(2):86-92. PubMed ID: 7793285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma brain natriuretic peptide levels increase in proportion to the extent of right ventricular dysfunction in pulmonary hypertension.
    Nagaya N; Nishikimi T; Okano Y; Uematsu M; Satoh T; Kyotani S; Kuribayashi S; Hamada S; Kakishita M; Nakanishi N; Takamiya M; Kunieda T; Matsuo H; Kangawa K
    J Am Coll Cardiol; 1998 Jan; 31(1):202-8. PubMed ID: 9426041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B-type natriuretic peptide in children with atrial or ventricular septal defect: a cardiac catheterization study.
    Jan SL; Fu YC; Hwang B; Lin SJ
    Biomarkers; 2012 Mar; 17(2):166-71. PubMed ID: 22235950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.
    Yasue H; Yoshimura M; Sumida H; Kikuta K; Kugiyama K; Jougasaki M; Ogawa H; Okumura K; Mukoyama M; Nakao K
    Circulation; 1994 Jul; 90(1):195-203. PubMed ID: 8025996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of atrial and brain natriuretic peptides and cyclic guanosine monophosphate in response to dobutamine infusion in patients with surgically repaired tetralogy of fallot.
    Hayabuchi Y; Matsuoka S; Kuroda Y
    Pediatr Cardiol; 1999; 20(5):343-50. PubMed ID: 10441688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma brain natriuretic peptide and atrial natriuretic peptide concentrations correlate with left ventricular end-diastolic pressure.
    Haug C; Metzele A; Kochs M; Hombach V; Grünert A
    Clin Cardiol; 1993 Jul; 16(7):553-7. PubMed ID: 8348764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between plasma atrial natriuretic polypeptide concentration and hemodynamic measurements in children with congenital heart diseases.
    Kikuchi K; Nishioka K; Ueda T; Shiomi M; Takahashi Y; Sugawara A; Nakao K; Imura H; Mori C; Mikawa H
    J Pediatr; 1987 Sep; 111(3):335-42. PubMed ID: 2957477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma levels of natriuretic peptide type B and A in children with congenital heart defects with left compared with right ventricular volume overload or pressure overload.
    Holmgren D; Westerlind A; Lundberg PA; Wåhlander H
    Clin Physiol Funct Imaging; 2005 Sep; 25(5):263-9. PubMed ID: 16117728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paradoxical relationship between B-type natriuretic peptide and pulmonary vascular resistance in patients with ventricular septal defect and concomitant severe pulmonary hypertension.
    Toyono M; Harada K; Tamura M; Aoki-Okazaki M; Shimada S; Oyamada J; Takada G
    Pediatr Cardiol; 2008 Jan; 29(1):65-9. PubMed ID: 17786380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of natriuretic peptides and cyclic GMP in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Kato H; Anai H; Tsuda Y; Segawa K; Tanaka H; Tamura M; Takasugi M; Nakashima Y
    Am J Nephrol; 2001; 21(2):112-9. PubMed ID: 11359018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of digoxin on atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and cyclic 3', 5'-guanosine monophosphate (cGMP) in patients with chronic congestive heart failure].
    Kobusiak-Prokopowicz M; Swidnicka-Szuszkowska B; Mysiak A
    Pol Arch Med Wewn; 2001 Jun; 105(6):475-82. PubMed ID: 11865578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of long-term treatment with prostacyclin on plasma adrenomedullin in patients with primary pulmonary hypertension].
    Nakayama T; Ishikita T; Matsuura H; Saji T
    J Cardiol; 2001 Nov; 38(5):263-71. PubMed ID: 11729726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of plasma levels of mature adrenomedullin and natriuretic peptide as markers of cardiac function in hemodialysis patients with coronary artery disease.
    Osajima A; Okazaki M; Tamura M; Anai H; Kabashima N; Suda T; Iwamoto M; Ota T; Watanabe Y; Kanegae K; Nakashima Y
    Nephron; 2002 Dec; 92(4):832-9. PubMed ID: 12399629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of increased plasma levels of brain natriuretic peptide in patients with septic shock.
    Ueda S; Nishio K; Akai Y; Fukushima H; Ueyama T; Kawai Y; Masui K; Yoshioka A; Okuchi K
    Shock; 2006 Aug; 26(2):134-9. PubMed ID: 16878020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure.
    Clerico A; Iervasi G; Del Chicca MG; Emdin M; Maffei S; Nannipieri M; Sabatino L; Forini F; Manfredi C; Donato L
    J Endocrinol Invest; 1998 Mar; 21(3):170-9. PubMed ID: 9591213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased brain and atrial natriuretic peptides in patients with chronic right ventricular pressure overload: correlation between plasma neurohormones and right ventricular dysfunction.
    Tulevski II; Groenink M; van Der Wall EE; van Veldhuisen DJ; Boomsma F; Stoker J; Hirsch A; Lemkes JS; Mulder BJ
    Heart; 2001 Jul; 86(1):27-30. PubMed ID: 11410557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure.
    Yoshimura M; Yasue H; Okumura K; Ogawa H; Jougasaki M; Mukoyama M; Nakao K; Imura H
    Circulation; 1993 Feb; 87(2):464-9. PubMed ID: 8425293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does N-terminal pro-brain natriuretic peptide correlate with measured shunt fraction in children with septal defects?
    Ozyurt A; Baykan A; Argun M; Pamukcu O; Uzum K; Narin F; Narin N
    Cardiol Young; 2016 Mar; 26(3):469-76. PubMed ID: 25858635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.